December 4, 2024
We recently hosted our December 2024 Q4 Product Update Webinar, showcasing significant enhancements to the CDD Vault platform. The webinar covered four key modules: Curves and AI. Let's dive into the exciting updates for each module.
Curves
The new Curves module streamlines data analysis and visualization, offering:
- Area Under the Curve (AUC) calculation
- Replicate point visualization
- Enhanced bell-shaped curve fitting
- Updated color-coding logic
The demonstration showcased how you can have the ability to take on more agency with your data by utilizing a growing library of curve fitting algorithms to analyze stored data in CDD's multi-modal platform.
Our goal is to make CDD Vault the single platform to work with from data collection, to data collaboration, to data reporting to “publicize” your story.
If you'd like to see how the Curves module can enhance your research workflow, request a personalized demo today.
AI
CDD Vault's AI capabilities now include:
- Fast similarity search in ChEMBL, SureCHEMBL, CDD Public data and Enamine Screening collection
- Bioisosteric suggestions
- API: QSAR/inverse QSAR - optimizing and navigating in latent space
- New AI support chatbot integration
The demonstration highlighted how various new deep learning AI tools to accelerate drug discovery by enhancing speed, accuracy, and efficiency.
Interested in exploring how AI can boost your drug discovery efforts? Request a customized demo of the AI module.
The CDD Vault Q4 2024 Product Update introduces powerful new features across all key modules, designed to enhance efficiency, collaboration, and data-driven insights in drug discovery. These updates reflect CDD's commitment to continually improving their platform based on user feedback and emerging research needs.
To learn more about any of these modules or to see how they can be tailored to your specific workflow, don't hesitate to reach out for a customized demo or additional resources.
If you would like to the full Americas or Eurasia Webinar, click your webinar session of choice below.
|
|
|